In the past two decades, several groups have been instrumental in developing novel strategies for hemophilia A gene therapy using platelets as a target (11C20)
In the past two decades, several groups have been instrumental in developing novel strategies for hemophilia A gene therapy using platelets as a target (11C20).… Read More »In the past two decades, several groups have been instrumental in developing novel strategies for hemophilia A gene therapy using platelets as a target (11C20)